Companies formed

Since 1997, Oxford University Innovation has been responsible for creating spinout companies based on academic research generated within and owned by the University of Oxford, and has spun out a new company every two months on average.

Over £2.1bn in external investment has been raised by Oxford University Innovation spinouts since 2010, and eleven are currently listed in London and New York.

The creation of new spinout companies, most of which are listed below, also channels millions of pounds back into University research, benefits local economic development and has created many new jobs in the region.

2019

GryeOx addresses significant unmet need in drug discovery as the IP can make expanded drug libra of macrocycles in the hit to lead stage.

Incorporated in July 2019

Origin: Oxford University

DNA assembly.

Incorporated in July 2019

Origin: Oxford University

"CRIS" software that enables submission, de-identification and sharing of mental health patient records using a federated data and information governance model.

Incorporated in May 2019

Origin: Oxford University, Psychiatry

Will develop optimisation codes for a number of sector, starting with the optimisation of nuclear fusion processes.

Incorporated in May 2019

Origin: Oxford University, Physics

Ion traps based quantum computing

Incorporated in April 2019

Origin: Oxford University, Physics

Ion traps based quantum computing.

Incorporated in April 2019

Origin: Oxford University, Physics

To develop compound libraries based on the asymmetric synthesis methodolofies.

Incorporated in March 2019

Origin: Oxford University, Chemistry

2018

Will produce a new, scalable route to Cannabidiol.

Incorporated in December 2018

Origin: Oxford University, Chemistry

OxStem Immuno aims to develop small molecule drugs that augment macrophage efferocytosis in
vitro and enhance tissue repair in vivo. These therapies will supercede the need for cell transplantation
or cytokine therapy in the context of tissue repair for chronic wounds and a range of inflammatory
conditions.

Incorporated in December 2018

Origin: Oxford University, Department of Physiology, Anatomy and Genetics

Contact: Adam Workman

OxStem Beta will generate novel therapies to stimulate formation of new beta cells in the pancreas
(neogenesis) by targeting pathways that are normally only active during development or following
pancreatic injury.

Incorporated in December 2018

Origin: Oxford University, Pathology

A not for profit company providing a solution and accreditation to businesses that work to bring their workforce out of multidimensional poverty

Incorporated in November 2018

Origin: Oxford University, International Development

Contact: Mark Mann

Developing a brain implant to treat a variety of diseases.

Incorporated in October 2018

Origin: Oxford University, Nuffield Department of Surgical Sciences

LED spin-out using Perovskite technology.

Incorporated in September 2018

Origin: Oxford University, Physics

Development and application of bacterial biosensors for detection and quantification of environmental contamination, including organics and metals, on-site and in real-time.

Incorporated in August 2018

Origin: Oxford University, Engineering

Contact: Andy Robertson

A company being established to commercialise Zooniverse technology

Incorporated in July 2018

Origin: Oxford University, Physics

Software development for a novel biomarker to detect coronary heart disease.

Incorporated in July 2018

Origin: Oxford University, Radcliffe department of medicine

Contact: James Groves

Search

Ready to get in touch?

Contact Us
Search
© Oxford University Innovation